Randomised Controlled Trial Of Two Doses Of Heparin In Cerebral Venous Thrombosis
Cerebral venous thrombosis accounts for 10-20% of strokes in the young in India. Over the past decade, heparin has become the mainstay of treatment of cerebral venous thrombosis. The conventional doses of heparin require strict monitoring of activated partial thromboplastin time. Effic...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2005-01-01
|
Series: | Annals of Indian Academy of Neurology |
Online Access: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2005;volume=8;issue=4;spage=233;epage=236;aulast=Sarma;type=0 |